Artwork

Content provided by Scott Wagers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Scott Wagers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Understanding Car-T Cell Therapy And Improving Laboratory Leadership With Dr. Michael Hudecek

36:26
 
Share
 

Manage episode 357303235 series 3401918
Content provided by Scott Wagers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Scott Wagers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Through the power of engineered cell therapy, we have the potential to revolutionize cancer treatment and bring hope to millions of patients worldwide. But true success lies not only in the science but also in the leadership that guides it. In this episode, we have the pleasure of having Dr. Michael Hudecek, a distinguished researcher and academic coordinator of the T2Evolve project. Michael has been instrumental in spearheading the development of CAR-T cell therapy, one of the most promising treatments for cancer patients. Our conversation with Michael delves into his research, discussing the latest advancements and discoveries in the field of CAR-T therapy. But that's not all. Dr. Hudecek also shares his insights on what it takes to be an effective leader of a lab group and how to lead a successful team with the right skills. Join us as we explore the world of engineered cell therapy and gain valuable insights from one of the leading researchers in Europe.

  continue reading

12 episodes

Artwork
iconShare
 
Manage episode 357303235 series 3401918
Content provided by Scott Wagers. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Scott Wagers or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Through the power of engineered cell therapy, we have the potential to revolutionize cancer treatment and bring hope to millions of patients worldwide. But true success lies not only in the science but also in the leadership that guides it. In this episode, we have the pleasure of having Dr. Michael Hudecek, a distinguished researcher and academic coordinator of the T2Evolve project. Michael has been instrumental in spearheading the development of CAR-T cell therapy, one of the most promising treatments for cancer patients. Our conversation with Michael delves into his research, discussing the latest advancements and discoveries in the field of CAR-T therapy. But that's not all. Dr. Hudecek also shares his insights on what it takes to be an effective leader of a lab group and how to lead a successful team with the right skills. Join us as we explore the world of engineered cell therapy and gain valuable insights from one of the leading researchers in Europe.

  continue reading

12 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide